Bionomics (BNOX) Institutional Ownership $0.24 -0.01 (-2.88%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Bionomics (NASDAQ:BNOX)CurrentInstitutional OwnershipPercentage15.90%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$940.92KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$164.75K Get BNOX Insider Trade Alerts Want to know when executives and insiders are buying or selling Bionomics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BNOX Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Bionomics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024 Lynx1 Capital Management LP599,673$460K0.2%-26.4%7.349% 8/15/2024 Armistice Capital LLC1,226,759$941K0.0%N/A15.034% 11/14/2023 Lynx1 Capital Management LP815,512$2.20M1.5%N/A9.994% 8/16/2022 Woodline Partners LP141,007$986K0.0%-12.4%2.518% 5/6/2022Light Sky Macro LP157,261$1.35M100.0%-19.4%2.808% 2/19/2022 Woodline Partners LP161,943$2.03M0.0%N/A2.893% 2/11/2022Light Sky Macro LP195,162$2.45M1.9%N/A3.486% (Data available from 1/1/2016 forward) BNOX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BNOX shares? During the previous two years, the following institutional investors and hedge funds held shares of Bionomics shares: Armistice Capital LLC ($941K), Lynx1 Capital Management LP ($460K).Learn more on BNOX's institutional investors. What percentage of Bionomics stock is owned by institutional investors? 15.90% of Bionomics stock is owned by institutional investors. Learn more on BNOX's institutional investor holdings. Which institutional investors have been buying Bionomics stock? The following institutional investors have purchased Bionomics stock in the last 24 months: Armistice Capital LLC ($1.23M), and Lynx1 Capital Management LP ($815.51K). How much institutional buying is happening at Bionomics? Institutional investors have bought a total of 2,042,271 shares in the last 24 months. This purchase volume represents approximately $3.14M in transactions. Which Bionomics major shareholders have been selling company stock? The following institutional investors have sold Bionomics stock in the last 24 months: Lynx1 Capital Management LP ($214.79K). How much institutional selling is happening at Bionomics? Institutional investors have sold a total of 214,794 shares in the last 24 months. This volume of shares sold represents approximately $164.75K in transactions. Related Companies CTXR Institutional Ownership TENX Institutional Ownership CGTX Institutional Ownership FNCH Institutional Ownership CARM Institutional Ownership MIRA Institutional Ownership UBX Institutional Ownership CVKD Institutional Ownership PIRS Institutional Ownership SYBX Institutional Ownership This page (NASDAQ:BNOX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionomics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
